• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Idiopathic Pulmonary Fibrosis: How to Recognize and When to Refer

Slideshow

This compact yet detailed slide show offers primary care physicians a guide to essentials of IPF diagnosis and when to refer for pulmonary consult.

Recent Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Respiratory Virus Season 2024-2025: Expert Insights to Help Primary Care Prepare

Sydney Jennings
November 11th 2024
Article

Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.

Respiratory Tripledemic 2022-23: An Expert Recap

Respiratory Tripledemic 2022-23: An Expert Recap

Sydney Jennings
April 6th 2023
Podcast

William Schaffner, MD, medical director of the NFID, provides an expert recap of the 2022-2023 respiratory virus season for primary care clinicians.

Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy / Image credit: ©MargJohnsonVA/AdobeStock

Investigational RSV Vaccine Yields Positive Preliminary Data in Head-to-Head Comparison with Arexvy

Sydney Jennings
October 29th 2024
Article

Preliminary phase 1 data showed that RSV neutralizing antibodies for non-adjuvanted SCB-1019 matched GSK’s AS01E-adjuvanted RSV vaccine, Arexvy.

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half

Sydney Jennings
May 20th 2022
Podcast

In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.

FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose / image credit: ©New Africa/AdobeStock

FDA Approves First-Ever Biologic Medicine for COPD: Daily Dose

Sydney Jennings
October 8th 2024
Article

Your daily dose of the clinical news you may have missed.

Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma

Albuterol/Budesonide Reduces Risk of Exacerbation in People with Intermittent, Mild-Persistent Asthma

Grace Halsey
October 7th 2024
Article

Albuterol/budesonide (Airsupra) has now proven effective as novel combination as-needed rescue medication for adults with asthma regardless of disease severity.

© 2024 MJH Life Sciences

All rights reserved.